Page last updated: 2024-08-21

malondialdehyde and Granulocytic Leukemia, Chronic, Stable Phase

malondialdehyde has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harahap, A; Jusman, SW; Reksodiputro, AH; Rinaldi, I; Setiabudy, R; Suharti, C; Tambunan, K; Wanandi, SI	1

Other Studies

1 other study(ies) available for malondialdehyde and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role. Asian Pacific journal of cancer prevention : APJCP, 2019, Dec-01, Volume: 20, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Sectional Studies; Female; Humans; Hydroxyurea; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Malondialdehyde; Middle Aged; Protein Kinase Inhibitors; Retrospective Studies; Young Adult	2019

Article

Year

Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role.

Asian Pacific journal of cancer prevention : APJCP, 2019, Dec-01, Volume: 20, Issue:12

Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Sectional Studies; Female; Humans; Hydroxyurea; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Malondialdehyde; Middle Aged; Protein Kinase Inhibitors; Retrospective Studies; Young Adult

2019